Study title: An open, non-comparative, pilot study using magnetic resonance imaging (MRI) scans to investigate any arthropathic effects of a 14 day course of ciprofloxacin bd oral tablets on the joints of children with Pseudomonas aeruginosa exacerbations of cystic fibrosis.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Bacterial Infections and Mycoses | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CIPROFLOXACIN | |||||
ATC code: | |||||
Document link: Bayer Pharma_Ciprofloxacin_1427_study_synopsis.pdf | |||||
Document date: 2011-09-07 | |||||
Study number: 1427 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |